ギャップを埋める:血液学的悪性疾患における緩和ケア統合の更新された体系的統合レビュー
Deborah Moreno-Alonso1, Beatriz García García2, Clara Madrid-Alejos3
1Comprehensive Cancer Support Area, ICAMS (Institute of Cancer and Blood Diseases), Hospital Clínic, Barcelona, Spain.
Seminars in oncology nursing
|August 21, 2025
まとめ
症状管理と感情的サポートの効果が証明されているにもかかわらず,血液学的悪性腫瘍の緩和ケアは十分に活用されていません. 誤った考え方を解消し 臨床医の訓練を向上させることが 適切なタイミングで治療を受けられるようにする上で 極めて重要です
科学分野:
- 血液学
- 緩和ケア
- 腫瘍 介護
背景:
- 血性悪性腫瘍の緩和ケアへの統合は,最新の評価を必要とします.
- 過去の調査では 介護の提供に欠陥があることが 明らかになった.
- 新しいテーマや変化を特定するために 10年更新が必要でした
研究 の 目的:
- 血性悪性腫瘍患者の10年間の緩和ケアにおけるギャップと変化を評価する.
- 緩和ケアにおける新たなテーマを特定する.
- ヘマトロジーサービスにおける緩和医療の統合を強化するための勧告を提供すること.
主な方法:
- 2015年7月から2024年12月までの文献の体系的なレビュー
- PubMed,CINAHL,Cochrane,Scopus,Web of Scienceなどで検索しました
- 以前に分析された記事は除外し,最近の変化とトレンドに焦点を当てた.
主要な成果:
- 68件の論文を分析し 6つのテーマを明らかにしました アクセス,終末期ケア,症状の負担,家庭でのケア,感情的なサポート,および様々な側面です.
- 血性悪性腫瘍の患者は 症状の重荷が高くても 緩和治療は十分に利用されていない.
- 障壁には誤解 コミュニケーションの欠如 臨床医の知識の欠如 制度的な問題などがあり 遅い段階での相談に繋がります
結論:
- 緩和ケアでは 症状の管理と 終末期の hematological 患者の感情的なサポートを 大幅に改善します
- 早期のアクセスを改善するために"緩和"を再定義する必要があります.
- 臨床医の知識の不足を 訓練を通じて解決することは 医療へのアクセス障壁を 解消するために不可欠です
関連する概念動画
Continuing Care
1.6K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Nursing Clinical Information System
864
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
864


